Calycosin, a bioactive component derived from Astragali Radix (AR; Huang Qi), has been shown to have an effect of anti-allergic dermatitis with unknown mechanism.
Calycosin, an isoflavonoid phytoestrogen isolated from Astragali Radix, was reported to possess antitumour and anti-inflammation properties. 7 The dried roots of Astragali Radix, called "Huang Qi" in Chinese,
are well known as a basic traditional Chinese medicine for thousands of years. "Huang Qi" has powerful immunomodulatory function and is widely used for treating dermatitis, chronic rhinitis, asthma and glomerulonephritis. [8] [9] [10] Calycosin-7-O-β-D-glucoside and calycosin are the main active flavone of "Huang Qi," and the former would transform into the latter in vivo. 11 Our previous study showed that administration of calycosin in the initial stage of sensitization when the ear has not yet produced inflammation significantly reduced the ear inflammation in mice ACD model. 12 However, the impact of calycosin treated throughout the ACD model when a large number of inflammatory factors appear is unknown, and the mechanism is also worth exploring.
The epidermis of allergic dermatitis patients could have significant barrier disruption. 13 Epidermal barrier dysfunction is a prerequisite for the penetration of high molecular weight allergens, such as pollens, house-dust mite products, microbes and food. 14, 15 A disturbed barrier alone could drive dendritic cells to enhance Th2 polarization in patients with AD through elevated antigen permeation. 16 In recent years, more and more researches have demonstrated that the dysregulation of the epithelial barrier might enhance susceptibility and result in the allergen uptake, which initiates an allergic immune response by promoting the release of interleukin (IL)-25, IL-33 and thymic stromal lymphopoietin (TSLP), 17 which are key initiators of allergic diseases leading to the induction and maintenance of Th2 responses. 18, 19 The impairment of epidermal tight junctions can induce immune dysregulation in allergic dermatitis, 20 and disruption of tight junctions was demonstrated by down-regulation of a variety of proteins including CLDN1, occludin and ZO-1. CLDN1 regulates the pathogenesis, severity and natural course of human AD, and reduced levels of CLDN1 in AD skin have been inversely correlated with expression of Th2 markers and a propensity to infection. [21] [22] [23] It is noteworthy that restoring the expression of CLDN1 alleviates atopic dermatitis. 24 So regulating tight junctions might involve in the mechanism of attenuation of AD.
AD is characterized by an increase in the release of local inflammatory factors, such as IL-1β, TNF-α and Th2 cytokines. 25, 26 Many studies have shown that inflammatory cytokines play a vital role in the dysregulation of the epithelial barrier function. 27, 28 HIF-1α can be activated by these inflammatory mediators and can activate inflammation-modulating proteins itself. 29 Therefore, HIF-1α may relate to the regulation of the epithelial barrier function. Furthermore, the role of HIF-1α in inflammatory reactions associated with dermatitis has recently become evident. 30 It is reported that UVB exposure may increase TSLP expression in keratinocytes through a HIF-1α-dependent mechanism. 31 Moreover, a murine study has demonstrated that HIF-1α protein is an early responder to UV radiation in the skin. 32, 33 HIF-1α may be an important pathway involved in processes such as delivery of "second signals" in contact hypersensitivity reactions to allergen. 34 Although some plant isoflavones were reported to exert inhibition effect on HIF-1α, the effect of calycosin on it in the context of allergic inflammation remains to be illustrated. Therefore, HIF-1α is likely to play a role in AD and the anti-allergy mechanism of calycosin may relate to it.
| MATERIALS AND METHODS

| Cell lines
HaCaT keratinocytes derived from ATCC (Manassas, VA, USA) were obtained from the National Infrastructure of Cell Line Resource (Beijing, China). HaCaT cells were cultured in modified Eagle's medium (MEM) supplemented with 10% foetal bovine serum (FBS, Gibco) and penicillin/streptomycin (BioSharp) in a 5% CO 2 incubator (Thermo).
| Animal
BALB/c mice were purchased from Shanghai Slack Laboratory Animal Co., Ltd. All animals were housed in a specific pathogen-free facility at 18-25°C and 40%-70% humidity and were used at 6-8 weeks of age. All procedures involving animals were approved by the Animal Care and Use
Committee of Nanjing University of Chinese Medicine and performed strictly according to the Guide for the Care and Use of Laboratory.
| Reagents and chemicals
The reagents used in this study were purchased as follows. Primers were ordered from GenScript (Nanjing, China). Calycosin was purchased from Tianjin Vientiane Hengyuan Technology Co., Ltd (China, Purity: ≥99%). Dexamethasone was a product from Tianyao Pharmaceutical Co., Ltd (Hubei, China). 2-ME and DMOG were obtained from Selleck (Shanghai, China). LPS (lipopolysaccharides) were purchased from Sigma (Sigma-Aldrich China, Shanghai, China). TNF-α and IL-1β were obtained from PeproTech (New Jersey, USA).
| Mouse Th2-mediated ACD model
After acclimatization for 3 days, the abdomens of BALB/c mice were shaved with a razor over an area of about 3 × 3 cm 2 . The abdominal skin of the mice was treated with 1.5% FITC (Sigma, St. Louis, MO, USA) in 80 μL of acetone and dibutylphthalate (1:1; vehicle) on days 1 and 2, and ears were treated with 20 μL of 0.6% FITC solution on day 6. On day 7 (24 hours after elicitation), ear thickness was measured with a thickness gauge (7301; Mitutoyo, Kawasaki, Japan), and ear swelling was calculated (ear thickness in each group minus the average ear thickness in the control group). The mice were then killed, and ear tissues were collected. The levels of IL-4, IL-5 and IL-13 in ear tissue homogenate were detected by ELISA. Histopathological changes of the ears were determined by HE staining.
| Drug administration
A: The dose-response study of calycosin in ACD model B: The effect investigation of 2-ME on ACD.
The establishment of FITC-induced ACD model is as described above. Mice were treated once daily with 2-ME (50 mg/kg, intraperitoneally) in the whole course of ACD model. 
| Western blotting
Western blotting was performed to assess the changes in the protein expression levels of HIF-1α, CLDN1, occludin, ZO-1, TSLP and IL-33.
HaCaT cells were homogenized in assay lysis buffer (RIPA: phenylmethylsulfonyl fluoride = 100:1 
| Histological and immunohistochemical analysis
Ears were fixed in 10% neutral formalin, embedded in paraffin and sectioned. Dry tissue sections of 5 μm thickness at 60°C constant temperature box were baked for 30 minutes. Slides were undergone dewaxing, and hydration was performed with sequential dimethylbenzene soak for 20 minutes. Sequential ethanol soaks were carried out for 3 minutes, each starting 100% ethanol for twice, followed by 95%, 80% and 75% ethanol, and finishing with a 50% ethanol. Antigen was retrieved by citric acid buffer water bath heating by microwave oven at high fire for 12 minutes, followed by adding the buffer twice at high fire for 5 minutes every time and then restored at room temperature.
Block endogenous peroxidase by incubating 10 minutes in 3% H 2 O 2 .
Block non-specific binding sites with 10% normal goat serum for 
| Immunofluorescence analysis
The changes in the expressions and distribution of CLDN1, occludin and ZO-1 were analysed by immunofluorescence analysis. for 10 minute at room temperature. Between each step, the cells were extensively rinsed 3 times for 3 minutes each time. Staining was assessed with a live cell work station microscope (Carl Zeiss Jena).
| Transfection with siRNA for HIF-1α in HaCaT
In all experiments, 150 pmol siRNA (the target sequence of HIF-1α-
Bio, Shanghai, China) were used to transfect 40%-50% confluent cells according to the manufacturer's instructions. The Lipofectamine siRNA into HaCaT cells growing in serum-free opti-MEM media.
After 6 hours, the medium containing the siRNA-lipid complexes was replaced with MEM containing 10% FBS. After transfection for 48 hours, the cells were stimulated with IL-1β, and then, subsequent experiments were completed.
| The transfection with pLenti-CMV-HIF-1α in
HaCaT cells
HaCaT HaCaT cells growing in serum-free opti-MEM media. After 6 hours, the medium was replaced with MEM containing 10% FBS. And subsequent experiments were completed 24 hours after transfection. 
| RNA isolation and quantitative real-time PCR
| Enzyme-linked immunosorbent assay (ELISA)
Ears were ground into homogenates with ice-phosphate-buffered saline (PBS), and the homogenates were centrifuged at 3500 g at 4°C for 10 minutes. ELISAs were performed to relatively quantify protein in the ear tissue homogenate. All of the procedures followed the manufacturer's instructions. Mouse TNF-α, IL-1β, IL-4,IL-5 and IL-13 ELISA kit were obtained from eBioscience Co., Ltd (San Diego, CA, USA). CA, USA). The differences were considered significant for P < .05.
| Statistical analysis
| RESULTS
| Calycosin inhibited allergic inflammation in FITC-induced mice ACD model
To evaluate the activity of calycosin against ACD, a dose-response study was carried out. In ACD model, mice were treated daily with calycosin (2, 10 and 50 mg/kg), DEX (0.67 mg/kg) or normal saline (model group) for 7 days during the course of the experiment. Ear tissues were collected 24 hours after the final FITC challenge (Figure 1A) . It showed that the ear swelling, inflammatory cell infiltration and oedema were significantly inhibited by calycosin in a dosedependent manner ( Figure 1B,C) . Moreover, the levels of IL-4, IL-5
and IL-13 in the ear tissues were also obviously inhibited by calycosin treatment ( Figure 1D ). In addition, the total inhibition rate of each dose (2, 10 and 50 mg/kg) is, respectively, 28.4%, 41.0% and 58.0%, and the ID50 was calculated to be 22.95 mg/kg. These results indicated that calycosin inhibits allergic inflammation in a dosedependent manner in mice Th2 ACD model. 
| Epithelial tight junctions were repaired by calycosin in ACD mice model
To investigate the effect of calycosin on regulating the TJs, immunohistochemistry was performed to detect the expression of CLDN1, occludin and ZO-1. The results showed that epithelial tight junctions in ACD model were deteriorated obviously compared with those in control mice, which was characterized by the decrease of CLDN1 (Figure 2A ),occludin ( Figure 2B ) and ZO-1 ( Figure 2C ). In contrast to the feebler effect of dexamethasone, calycosin up-regulated the expression of these tight junctions significantly.
| Calycosin repaired epithelial tight junctions in
HaCaT cells F I G U R E 1 Calycosin inhibited FITC-induced ACD-associated allergic inflammation. A, Flow charts of the FITC-induced ACD model. In ACD model, mice were treated daily with calycosin (2, 10 or 50 mg/kg, intraperitoneally), DEX (0.67 mg/kg, intraperitoneally) or normal saline (model group) for 7 days during the whole course of the experiment. B, Ear swelling was calculated on day 7 in the ACD model mice (means + SD, n = 6, ### P < .001 vs control; ***P < .001, **P < .01 vs model). C, Haematoxylin and eosin (H&E)-stained ear skin sections from FITC-induced ACD mice model (n = 5; magnification: ×200). D, Calycosin reduced the levels of cytokines IL-4, IL-5 and IL-13 in the ear tissue homogenates of the mouse model of ACD (mean + SD, n = 6, ### P < .001 vs control; ***P < .001, **P < .01, *P < 0.05 vs model)
| Calycosin reduced the expression of HIF-1α both in vivo and in vitro
To address the effect of calycosin on the expression of HIF-1α, These results suggested that calycosin down-regulated the HIF-1α expression both in vivo and in vitro.
| Knocking-down HIF-1α reversed the down-regulation of occludin and the redistribution of CLDN1 and ZO-1 induced by IL-1β in HaCaT cells
HaCaT cells were stimulated with LPS, TNF-α or IL-1β, respectively, for 24 hours, and the results showed that IL-1β was the most significant factor in increasing the expression of HIF-1α ( Figure 5A ) in a dose-dependent manner ( Figure 5B ). However, increasing concentrations of FITC (0.1, 1, 10 and 100 μmol/L) exposure had no detectable change in the protein expressions of HIF-1α ( Figure 5C ). The nuclear translocation of HIF-1α was higher in IL-1β-stimulated cells than that in the controls ( Figure 5D ), which indicates that IL-1β induces the stabilization of HIF-1α, leading to its nuclear translocation. Meanwhile, the mRNA levels of HIF-1α, TNF-α and IL-1β were significantly F I G U R E 2 Calycosin improved epithelial tight junctions of ACD mice. On day 7 in the ACD model, mice were killed, and then, the ears were removed and fixed by 10% formalin. A-C, IHC was performed to detect the expression of CLDN1, occludin and ZO-1 (n = 5, magnification: ×200). Data of IOD (integral optical density) were counted by IPP (Image-Pro Plus) software (mean + SD, n = 5, ***P < .001, **P < .01) 
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Then, we analysed the effect of HIF-1α on tight junctions by HIF-1α gene silence. Compared with that in the control, TNF-α and IL-1β expression decreased as a result of HIF-1α down-regulation at the F I G U R E 4 Calycosin reduced HIF-1α expression in ACD mice model and in HaCaT cells. A, On day 7 in the ACD model, mice were killed, and then, the ears were removed. The expression of HIF-1α in the total protein was detected by Western blot. The data are expressed as the mean + SD of the ratios of indicated protein to GAPDH, n = 6, ***P < .001, **P < .01, *P < .05. B, IHC was performed to detect the expression of HIF-1α. C, HaCaT cells were pre-treated with different concentrations of calycosin and DEX for 6 h and then costimulated with 30 ng/mL IL-1β for 24 h. Effects of calycosin on protein levels of HIF-1α in HaCaT cells were detected by Western blot. D, HaCaT cells were pre-treated with different concentrations of calycosin and DEX for 6 h and then costimulated with 30 ng/mL IL-1β for 6 h. Effects of calycosin on mRNA levels of HIF-1α in HaCaT cells were detected by real-time PCR. ## P < .01 vs control, ***P < .001, **P < .01 vs IL-1β, ▵▵ P < .01 vs DEX. The data are representatives of 3 independent experiments F I G U R E 5 Knocking-down HIF-1α reversed the tight junction damage induced by IL-1β. A, HaCaT cells were, respectively, stimulated with LPS (10 μg/mL), TNF-α (20 ng/mL) and IL-1β (30 ng/mL) for 24 h. Proteins in total cell lysates were separated by SDS-PAGE and immunoblotted with anti-HIF-1α, anti-TSLP, anti-IL-33 or anti-GAPDH, as indicated. B, HaCaT was stimulated, respectively, with increasing concentrations of IL-1β for 24 h, and the expression of HIF-1α was detected by Western blot. C, HaCaT cells were stimulated with increasing concentrations of FITC (0.1, 1, 10 and 100 μmol/L) for 24 h, then the total proteins were extracted, and Western blot was performed to detect the expression of HIF-1α. D, IL-1β promoted the nuclear translocation of HIF-1α protein. Nuclear and cytoplasmic fractions were prepared 24 h after IL-1β (30 ng/mL) stimulation. E, HaCaT cells were stimulated with IL-1β (30 ng/mL) for 4 h. Then, the relative mRNA expression of HIF-1α, TNF-α, IL-1β, TSLP, IL-33 and IL-25 were analysed by real-time PCR (mean + SD, n = 6, ***P < .001, **P < .01, *P < .05). F-H, HaCaT cells were transfected with control small interference RNA (siCtrl) or HIF-1α-specific siRNA (siHIF-1α). After 48 h, cells were stimulated with IL-1β (30 ng/mL) for 4 h. The relative mRNA levels of HIF-1α, TNF-α, IL-1β, occludin, CLDN1 and ZO-1 were measured by quantitative real-time RT-PCR (QRT-PCR). ***P < .001, *P < .05. I-J, HaCaT cells were transfected with control small interference RNA (siCtrl) or HIF-1α-specific siRNA. After 48 h, cells were stimulated with IL-1β (30 ng/mL) for 24 h, and Western blot and immunofluorescence were performed to detect the expression and distribution of CLDN1, occludin and ZO-1 (n = 3; magnification: × 400). The data are representatives of 3 independent experiments mRNA level (Figure 5F,G) . Our results suggested that there was a circulation between IL-1β and HIF-1α. HIF-1α may act as an amplifier for inflammatory signal and IL-1β response, which contributed to the formation of pro-allergic and pro-inflammatory microenvironment in HaCaT cells. Given that IL-1β induced the expression of HIF-1α, as well as the damage of tight junctions, there may exist link between HIF-1α and tight junctions. After HIF-1α was knocked down by transfecting the specific siRNA for 48 hours, the mRNA expressions of occludin and CLDN1 in IL-1β-stimulated cells were increased significantly compared with that expressed in control ( Figure 5H ). Protein expressions of CLDN1, occludin and ZO-1 were consistent with the results of PCR.
Meanwhile, the expressions of TSLP and IL-33 were down-regulated by knocking-down HIF-1α ( Figure 5I ). Immunofluorescence assays further showed that HIF-1α silencing could reverse the deterioration of occludin, ZO-1 and CLDN1 induced by IL-1β ( Figure 5J ). Taken together, these findings suggested that HIF-1α plays a critical role in the damage of tight junctions.
| HIF-1α inhibitor administered in ACD mice
attenuated allergic inflammation and repaired the tight junctions 2-ME, an inhibitor of HIF-1α, 40 was administered daily to further determine the effect of HIF-1α on epithelial tight junction and the follow-up allergic inflammation. The ear swelling and inflammatory cell infiltration were significantly suppressed by 2-ME ( Figure 6A,B) .
The levels of TNF-α, IL-1β and IL-13, as well as HIF-1α, could be remarkably reduced by 2-ME ( Figure 6C,D) . 2-ME could also repair the tight junctions by means of up-regulating the expression of CLDN1, occludin and ZO-1 ( Figure 6E ).
| Calycosin repaired the tight junctions by down-regulating the HIF-1α expression in HaCaT cells
To further testify the role of HIF-1α in calycosin-regulated tight junc- Figure 7C,D) . We found that cell morphology changed after HIF-1α overexpressed ( Figure 7E ) and the expressions of occludin and CLDN1 were significantly reduced ( Figure 7F ). After transfection with HIF-1α, the expression of HIF-1α itself was reduced by calycosin significantly. Moreover, the reduced expressions of occludin and CLDN1 could be reversed by calycosin ( Figure 7G,H) . These results suggested that calycosin repaired the tight junctions by down-regulating the HIF-1α.
| DISCUSSION
When allergic dermatitis occurs, it was often accompanied by itching and scratching, which seriously impairs the quality of life. The hallmarks of atopic dermatitis are a chronic, relapsing form of skin inflammation, a disturbance of epidermal barrier function that culminates in dry skin. 16 Although anti-inflammatory treatments might reduce the disease severity by suppressing the immune reaction, they do not fully improve the barrier abnormalities that drive disease pathogenesis in AD. Currently, glucocorticoids are the most commonly used drugs for the treatment of allergic dermatitis, but the long-term application of glucocorticoid often causes serious side effects and it cannot alleviate the recurrence of the disease. 41 Previously, by cell chromatography, our group identified that calycosin can be effectively combined with 16HBE, an airway epithelial cell line. 12 In this study, the results showed its effect on repairing epithelial barrier, especially improving the expressions of tight junction proteins such as occludin, ZO-1 or CLDN1 either in vitro and in vivo. This result might indicate that repairing the tight junctions can relieve the symptoms and episodes of allergic dermatitis. Recent studies also suggest that prevention of AD can be achieved by early interventions protecting the skin barrier. 42 When exposed to allergens again, repairing the epithelial barrier may become a new strategy for the treatment of allergic dermatitis. 43 Measures directed at protecting the skin barrier are essential in the treatment of patients with AD, and early intervention may improve outcomes for both the skin disease and other target organs.
Considering the mechanism of calycosin repairing the tight junctions, we investigated HIF-1α. It has been reported that calycosin reduced NF-κB activation in LPS-stimulated human keratinocytes 44 and LPS induced HIF-1α protein accumulation by activating NF-κB. 45 Moreover, the role of HIF-1α in allergic diseases has been increasingly recognized. 46, 47 A previous study showed that HIF-1α increases epithelial permeability in human nasal epithelium. 48 Moreover, tight junction proteins are indicated as MMP (matrix metalloproteinases)
F I G U R E 6 2-ME inhibited ACD-associated inflammation and repaired the tight junctions. A, Ear swelling was calculated on day 7 in the ACD mice model (means + SD, n = 6, ### P < .001 vs control; **P < .01 vs model). B, Haematoxylin and eosin (H&E)-stained ear skin sections from FITC-induced ACD model mice (n = 5; magnification: ×100). C, The expressions of HIF-1α in the total protein were detected by Western blot. The data are expressed as the mean + SD of the ratios of indicated protein to GAPDH. **P < .01, *P < .05. D, The levels of cytokines IL-4, IL-13, TNF-α and IL-1β in the ear tissue homogenates were detected by ELISA (mean + SD, n = 6, ### P < .001 vs control; **P < .01 vs model). E, IHC was performed to detect the expression and distribution of CLDN1, occludin and ZO-1 (n = 5, magnification: ×200). Data of IOD (integral optical density) were counted by IPP (Image-Pro Plus) software (mean + SD, n = 5, ***P < .001)
substrates. Both occludin and the scaffolding protein ZO-1 are the substrates for gelatinases, and HIF-1α can trigger MMP activation. 49 We considered that HIF-1α regulated tight junction proteins. In our study, by silencing or overexpressing HIF-1α in vitro,we demonstrated that HIF-1α plays a critical role in regulating the inflammation microenvironment and tight junctions. Also, we found that HIF-1α could be significantly reduced by calycosin both in ACD mice model analysed via Western blotting with the specified antibody and real-time PCR with specified primers (means + SD, n = 6, ***P < .001 vs pLenti). E, The morphological changes were observed. F, The expressions of occludin and CLDN1 were detected by Western blot. G, The effect of calycosin on HIF-1α expression was detected by Western blot after transfected with pLenti-HIF-1α. H, The effect of calycosin on tight junctions was detected by immunofluorescence (n = 3; magnification: ×400). The data are representatives of 3 independent experiments both parental and pLenti-transfected cells showed a typical cuboidal epithelial shape. This implied that HIF-1α might change the polarity of epithelial cells, which was also reported in other researches. 51 To investigate how HIF-1α is up-regulated in allergic dermatitis, manner by activating NF-κB. 29 UVB induces HIF-1α expression via the JNK, ERK and P38 pathways in human keratinocytes. 31 Calycosin reduced NF-κB activation in TNF-α-stimulated 16HBE cells or LPS-stimulated human keratinocytes. 12, 44 Calycosin inhibits the phosphorylation of ERK 1/2 and NF-κB. 7, 57 Hence, calycosin may also regulate the expression of HIF-1α by transcriptional regulation.
Our results in vitro also showed that the knockdown of HIF-1α
in HaCaT cells can reverse the levels of TSLP and IL-33 induced by IL-1β. Some researches have shown that HIF-1α is associated with TSLP and IL-33. In UVB-mediated immune response in keratinocytes, UVB exposure may increase TSLP expression through a HIF-1α-dependent mechanism. 31 It has been reported that epithelial barrier dysfunction can lead to loss of adhesion between cells and cause the release of allergy-related cytokines, such as TSLP, in skin keratinocytes. 58 Recent research by our group showed that CLDN1 down-regulation in HaCaT cells could exacerbate the production of TSLP. 59 Calycosin may reduce the production of TSLP and IL-33 by repairing the tight junctions.
To conclude, calycosin may be a potential drug for the treatment of allergic dermatitis by regulating tight junctions via inhibiting the expression of HIF-1α, and as a consequence, HIF-1α and TJs might be possible therapy targets for allergic dermatitis. In addition, this study also suggests the theoretical possibility that the combined treatment of dexamethasone and calycosin might be a useful modality for allergic dermatitis treatment, and further studies involving the combined treatment of steroid and barrier repair therapies are needed.
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